Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B2 | P37059 | 7/20 | 0.51 |
| ▸ | UQCRB | P14927 | 3/20 | 0.51 |
| ▸ | PSD | A5PKW4 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | XBP1 | P17861 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | PGAM1 | P18669 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL207921 | 0.75 | LMNA (0.56) | LMNAMAPTMEN1XBP1KMT2A | |
| SCHEMBL4548216 | 0.75 | KMT2A (0.52) | LMNAMAPTMEN1XBP1KMT2A | |
| SCHEMBL4555041 | 0.73 | KMT2A (0.45) | LMNAMAPTMEN1XBP1KMT2A | |
| SCHEMBL4548215 | 0.71 | KMT2A (0.43) | LMNAMAPTMEN1XBP1KMT2A | |
| SCHEMBL13145359 | 0.70 | CHRM2 (0.78) | LMNAMAPTMEN1XBP1KMT2A | |
| SCHEMBL4548214 | 0.70 | MAPT (0.50) | LMNAMAPTMEN1XBP1KMT2A | |
| SCHEMBL15630053 | 0.69 | CHRM2 (0.63) | LMNAMAPTMEN1XBP1KMT2A | |
| SCHEMBL15623303 | 0.68 | KMT2A (0.56) | LMNAMAPTMEN1XBP1KMT2A | |
| SCHEMBL17694703 | 0.68 | GAA (0.45) | HSD17B2LMNAMAPTMEN1XBP1 | |
| SCHEMBL2715943 | 0.67 | LMNA (0.74) | LMNAMAPTMEN1XBP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088816-B2 | 3-3-di-substituted-oxindoles as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-01-03 | — | — | US | claimed |
| US-8044089-B2 | 3-3-di-substituted-oxindoles as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2011-10-25 | — | — | US | claimed |
| US-20100256388-A1 | 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-10-07 | — | — | US | claimed |
| US-7737172-B2 | 3-3-di-substituted-oxindoles as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-06-15 | — | — | US | claimed |
| US-8354440-B2 | 3-3-di-substituted-oxindoles as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2013-01-15 | — | — | US | disclosed |
| US-8268879-B2 | 3-3-di-substituted-oxindoles as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-09-18 | — | — | US | disclosed |
| US-20120077759-A1 | 3-3-Di-Substituted-Oxindoles as Inhibitors of Translation Initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-03-29 | — | — | US | disclosed |
| US-8088816-B2 | 3-3-di-substituted-oxindoles as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-01-03 | — | — | US | disclosed |
| US-8044089-B2 | 3-3-di-substituted-oxindoles as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2011-10-25 | — | — | US | disclosed |
| US-20110046367-A1 | 3-3-DI-SUBSTITUTED-OXINDOLES AS INHIBITORS OF TRANSLATION INITIATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2011-02-24 | — | — | US | disclosed |
| US-7846962-B2 | 3-3-di-substituted-oxindoles as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-12-07 | — | — | US | disclosed |
| US-20100256388-A1 | 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-10-07 | — | — | US | disclosed |
| US-20100249201-A1 | 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-09-30 | — | — | US | disclosed |
| US-7737172-B2 | 3-3-di-substituted-oxindoles as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-06-15 | — | — | US | disclosed |
| US-20090299058-A1 | 3-3-DI-SUBSTITUTED-OXINDOLES AS INHIBITORS OF TRANSLATION INITIATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2009-12-03 | — | — | US | disclosed |
| US-20070099976-A1 | 3-3-DI-SUBSTITUTED-OXINDOLES AS INHIBITORS OF TRANSLATION INITIATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2007-05-03 | — | — | US | disclosed |
| EP-1718611-A1 | 3-3-DI-SUBSTITUTED-OXINDOLES AS INHIBITORS OF TRANSLATION INITIATION | The President and Fellows of Harvard College (US) | 2006-11-08 | — | — | EP | disclosed |
| WO-2005080335-A1 | 3-3-DI-SUBSTITUTED-OXINDOLES AS INHIBITORS OF TRANSLATION INITIATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2005-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256388-A1 | 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation | EIF2AK2, EIF5B, EIF4EBP1 | HSD17B2 3286/4885UQCRB 2424/4885PSD 2792/4885 |
| US-20090299058-A1 | 3-3-DI-SUBSTITUTED-OXINDOLES AS INHIBITORS OF TRANSLATION INITIATION | EIF2AK2, EIF5B, EIF4EBP1 | HSD17B2 3286/4885UQCRB 2424/4885PSD 2792/4885 |
| US-20070099976-A1 | 3-3-DI-SUBSTITUTED-OXINDOLES AS INHIBITORS OF TRANSLATION INITIATION | EIF2AK2, EIF5B, EIF4EBP1 | HSD17B2 3286/4885UQCRB 2424/4885PSD 2792/4885 |
| US-20120077759-A1 | 3-3-Di-Substituted-Oxindoles as Inhibitors of Translation Initiation | EIF2AK2, EIF5B, EIF4EBP1 | HSD17B2 3286/4885UQCRB 2424/4885PSD 2792/4885 |
| US-20110046367-A1 | 3-3-DI-SUBSTITUTED-OXINDOLES AS INHIBITORS OF TRANSLATION INITIATION | EIF2AK2, EIF5B, EIF4EBP1 | HSD17B2 3286/4885UQCRB 2424/4885PSD 2792/4885 |
| US-20100249201-A1 | 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation | EIF2AK2, EIF5B, EIF4EBP1 | HSD17B2 3286/4885UQCRB 2424/4885PSD 2792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.